SLA.L Regulatory News (SLA)

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the Central Bank of Ireland)i

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

UDG Healthcare plc

2. Reason for the notification (please tick the appropriate box or boxes):

[X] An acquisition or disposal of voting rights

[ ] An acquisition or disposal of financial instruments

[ ] An event changing the breakdown of voting rights

[X] Other (please specify)iii: A corrective disclosure to reflect the fact that the Issuer's Home Member State for the purposes of Transparency (Directive 2004/109/EC) Regulation 2007 is Ireland.

3. Details of person subject to the notification obligationiv :

Name: Aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios

City and country of registered office (if applicable): Edinburgh, Scotland

4. Full name of shareholder(s) (if different from 3.)v:

5. Date on which the threshold was crossed or reachedvi: 14/09//2017

6. Date on which issuer notified: 09/01/2019

7. Threshold(s) that is/are crossed or reached: 3%

8. Total positions of person(s) subject to the notification obligation:

% of voting rights attached to shares (total of 9.A)

% of voting rights through financial instruments(total of 9.B.1 + 9.B.2)

Total of both in % (9.A + 9.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.02

0.00

3.02

248,326,744

Position of previous notification (if applicable)

3.03

0.00

3.03

9. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii:

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

Indirect

Direct

Indirect

IE0033024807

N/A

7,492,900

N/A

3.02

SUBTOTAL A

7,492,900

3.02

B 1: Financial Instruments according to Regulation 17(1)(a) of the Regulations

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is exercised/converted.

% of voting rights

SUBTOTAL B.1

B 2: Financial Instruments with similar economic effect according to Regulation 17(1)(b) of the Regulations

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash settlementxii

Number of voting rights

% of voting rights

SUBTOTAL B.2

10. Information in relation to the person subject to the notification obligation (please tick the applicable box):

[ ] Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.xiii

[X] Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv:

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Standard Life Aberdeen plc

Aberdeen Asset Management PLC

Aberdeen Asset Managers Limited

Standard Life Aberdeen plc

Aberdeen Asset Management PLC

Aberdeen Asset Investment Group Limited

Aberdeen Asset Investments Limited

Standard Life Aberdeen plc

Standard Life Investments (Holdings) Limited

Standard Life Investments Limited

11. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of [date]

N/A

12. Additional informationxvi:

In reference to Section 10, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager.

This is a retrospective disclosure to reflect confirmation received from the Issuer that its Home Member State for the purposes of the Irish Transparency Rules is Ireland. Prior to this confirmation, the aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios had treated the Home Member State of UDG Healthcare plc as the United Kingdom and, as such, monitored the percentage of total voting rights held in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rules sourcebook.

This disclosure reflects that the voting rights effectively held indirectly by the underlying intermediate holding company, Aberdeen Asset Management PLC, ("AAM PLC") decreased below the 3% notifiable threshold due to trading on 14 September 2017. As at the date detailed in Section 5, Aberdeen Asset Management PLC effectively held the delegated voting rights to 2.99% of the shares in UDG Healthcare plc. Prior to this crossing AAM PLC effectively held 3.01% of the delegated voting rights.